glutathione and glutathione-s-transferase in detoxification mechanisms The role of anti-cancer drug resistance Hepatocyte glutathione S-transferase mu 2
Description
Most people experience results in stages
No human study has confirmed this happens at commercially used oral doses
Ergochromes: heretofore neglected side of ergot toxicity
Thioredoxin shapes the C
The incorporation of a ruthenium catalyst and carbon fluorinated moieties into polymeric nanoreactors is expected to provide an anticancer strategy for tumor-targeted catalytic anticancer therapy of hypoxic tumors
doi: 10.1001/ARCHOPHT.119.10.1417
